|
1
|
D'Silva KA, Dahm P and Wong CL: Does this
man with lower urinary tract symptoms have bladder outlet
obstruction? The rational clinical examination: A systematic
review. JAMA. 312:535–542. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Rademakers KL, van Koeveringe GA and Oelke
M: Detrusor underactivity in men with lower urinary tract
symptoms/benign prostatic obstruction: Characterization and
potential impact on indications for surgical treatment of the
prostate. Curr Opin Urol. 26:3–10. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Niemczyk G, Czarzasta K, Radziszewski P,
Wlodarski P and Cudnoch-Jedrzejewska A: Pathophysiological effect
of bladder outlet obstruction on the urothelium. Ultrastruct
Pathol. 42:317–322. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wiafe B, Adesida AB, Churchill T, Kadam R,
Carleton J and Metcalfe PD: Mesenchymal stem cell therapy inhibited
inflammatory and profibrotic pathways induced by partial bladder
outlet obstruction and prevented high-pressure urine storage. J
Pediatr Urol. 15:254.e1–254.e10. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Metcalfe PD, Wang J, Jiao H, Huang Y, Hori
K, Moore RB and Tredget EE: Bladder outlet obstruction: Progression
from inflammation to fibrosis. BJU Int. 106:1686–1694.
2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Islam SS, Mokhtari RB, El Hout Y, Azadi
MA, Alauddin M, Yeger H and Farhat WA: TGF-β1 induces EMT
reprogramming of porcine bladder urothelial cells into collagen
producing fibroblasts-like cells in a Smad2/Smad3-dependent manner.
J Cell Commun Signal. 8:39–58. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jiang X, Chen Y, Zhu H, Wang B, Qu P, Chen
R and Sun X: Sodium tanshinone IIA sulfonate ameliorates bladder
fibrosis in a rat model of partial bladder outlet obstruction by
inhibiting the TGF-β/Smad pathway activation. PLoS One.
10(e0129655)2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chen Y, Ma Y, He Y, Xing D, Liu E, Yang X,
Zhu W, Wang Q and Wen JG: The TGF-β1 pathway is early involved in
neurogenic bladder fibrosis of juvenile rats. Pediatr Res: Jan 19,
2021 (Epub ahead of print).
|
|
9
|
Agre P and Kozono D: Aquaporin water
channels: Molecular mechanisms for human diseases. FEBS Lett.
555:72–78. 2003.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Niu D, Bai Y, Yao Q, Zhou L, Huang X and
Zhao C: AQP2 as a diagnostic immunohistochemical marker for
pheochromocytoma and/or paraganglioma. Gland Surg. 9:200–208.
2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kim SO, Choi D, Song SH, Ahn KY, Kwon D,
Park K and Ryu SB: Effect of detrusor overactivity on the
expression of aquaporins and nitric oxide synthase in rat urinary
bladder following bladder outlet obstruction. Can Urol Assoc J.
7:E268–E274. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Wang Y, Zhou Y and Graves DT: FOXO
transcription factors: Their clinical significance and regulation.
Biomed Res Int. 2014(925350)2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Xing YQ, Li A, Yang Y, Li XX, Zhang LN and
Guo HC: The regulation of FOXO1 and its role in disease
progression. Life Sci. 193:124–131. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ide H, Mizushima T, Jiang G, Goto T,
Nagata Y, Teramoto Y, Inoue S, Li Y, Kashiwagi E, Baras AS, et al:
FOXO1 as a tumor suppressor inactivated via AR/ERβ signals in
urothelial cells. Endocr Relat Cancer. 27:231–244. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Xin Z, Ma Z, Hu W, Jiang S, Yang Z, Li T,
Chen F, Jia G and Yang Y: FOXO1/3: Potential suppressors of
fibrosis. Ageing Res Rev. 41:42–52. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Wang J, Chen Y, Gu D, Zhang G, Chen J,
Zhao J and Wu P: Ketamine-induced bladder fibrosis involves
epithelial-to-mesenchymal transition mediated by transforming
growth factor-β1. Am J Physiol Renal Physiol. 313:F961–F972.
2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Qian W, Cai X, Qian Q, Zhang W and Wang D:
Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal
transition in bleomycin-induced pulmonary fibrosis. J Cell Mol Med.
22:4354–4365. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Iwano M: EMT and TGF-beta in renal
fibrosis. Front Biosci (Schol Ed). 2:229–238. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Shrestha N, Chand L, Han MK, Lee SO, Kim
CY and Jeong YJ: Glutamine inhibits CCl4 induced liver fibrosis in
mice and TGF-β1 mediated epithelial-mesenchymal transition in mouse
hepatocytes. Food Chem Toxicol. 93:129–137. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lin S, Lian D, Liu W, Haig A, Lobb I,
Hijazi A, Razvi H, Burton J, Whiteman M and Sener A: Daily therapy
with a slow-releasing H2S donor GYY4137 enables early
functional recovery and ameliorates renal injury associated with
urinary obstruction. Nitric Oxide. 76:16–28. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Cardozo CP: Identification of
transcription factor-binding sites in the mouse FOXO1 promoter.
Methods Mol Biol. 1890:29–40. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Huang F, Wang Q, Guo F, Zhao Y, Ji L, An
T, Song Y, Liu Y, He Y and Qin G: FoxO1-mediated inhibition of
STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis
in diabetic kidney disease. EBioMedicine. 48:491–504.
2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yang L, Yang F, Zhao H, Wang M and Zhang
Y: Circular RNA circCHFR facilitates the proliferation and
migration of vascular smooth muscle via miR-370/FOXO1/cyclin D1
pathway. Mol Ther Nucleic Acids. 16:434–441. 2019.PubMed/NCBI View Article : Google Scholar
|
